Beam Therapeutics Inc.

NASDAQ (USD): Beam Therapeutics Inc. (BEAM)

Last Price

28.95

Today's Change

+0.25 (0.87%)

Day's Change

28.00 - 29.12

Trading Volume

185,944

Overview

Market Cap

2 Billion

Shares Outstanding

82 Million

Avg Volume

1,118,252

Avg Price (50 Days)

25.76

Avg Price (200 Days)

25.93

PE Ratio

-18.30

EPS

-1.58

Earnings Announcement

25-Feb-2025

Previous Close

28.70

Open

28.77

Day's Range

28.0 - 29.12

Year Range

20.84 - 49.5

Trading Volume

187,876

Price Change Highlight

1 Day Change

0.73%

5 Day Change

11.24%

1 Month Change

15.41%

3 Month Change

16.71%

6 Month Change

16.43%

Ytd Change

5.47%

1 Year Change

-3.05%

3 Year Change

-63.95%

5 Year Change

54.19%

10 Year Change

54.19%

Max Change

54.19%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-301, a liver-targeted development candidate for the treatment of patients with Glycogen Storage Disease Type Ia. It also develops therapies for alpha-1 antitrypsin deficiency; ocular diseases; and other liver, muscle, and central nervous system disorders. The company has an alliance with Boston Children's Hospital; a research and clinical trial collaboration agreement with Magenta Therapeutics, Inc.; license agreement with Sana Biotechnology, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration agreement with Pfizer Inc. and Apellis Pharmaceuticals, Inc.; and collaboration and license agreement with Verve Therapeutics, Inc. The company was incorporated in 2017 and is based in Cambridge, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment